Cargando…
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
Kidney transplant recipients (KTR) are at increased risk for COVID-19-associated complications. We aimed to describe the evolving epidemiology and outcome of PCR-documented SARS-CoV-2 infection in KTR followed at our institution from March 2020 to May 2022. The primary endpoint was hospitalization f...
Autores principales: | Papadimitriou-Olivgeris, Matthaios, Cipriano, Ana, Guggisberg, Nicolas, Kroemer, Marie, Tschopp, Jonathan, Manuel, Oriol, Golshayan, Dela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576844/ https://www.ncbi.nlm.nih.gov/pubmed/36267693 http://dx.doi.org/10.3389/ti.2022.10721 |
Ejemplares similares
-
Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series
por: Halfon, Matthieu, et al.
Publicado: (2022) -
Comparison of SARS-CoV-2 serological tests with different antigen targets
por: Coste, Alix T., et al.
Publicado: (2021) -
Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients
por: Bachmann, Friederike, et al.
Publicado: (2022) -
SARS-CoV-2 Vaccination-Induced Immunogenicity in Heart Transplant Recipients
por: Memenga, Felix, et al.
Publicado: (2023) -
SARS-CoV-2 and COVID-19: A Narrative Review
por: Blann, A. D., et al.
Publicado: (2022)